Lavipharm : Key Financial Figures First Quarter 2023
Posted at h
in --, Announcements, Consolidated Financial Results, Consolidated Financial Results 2023
Paiania, 4 May 2023 – Group Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) increased by 34% during the first quarter of 2023 and amounted to €2.46 million compared to €1.84 million during the relevant period of the previous year.